Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.4B | 7.2B | 5.4B | 4.6B |
| Cost of revenue | 2.8B | 4.6B | 3.3B | 3.0B |
| Gross profit | 1.6B | 2.6B | 2.1B | 1.7B |
| Operating expense | ||||
| Research & development | 87.5M | 100.3M | 89.2M | 70.5M |
| Selling general and admin | 530.1M | 804.6M | 547.5M | 457.9M |
| Other operating expenses | — | — | — | — |
| Operating income | 967.4M | 1.7B | 1.4B | 1.2B |
| Non operating interest income | ||||
| Income | 24.7M | 16.6M | 20.1M | 19.3M |
| Expense | 7.0M | 10.4M | 11.5M | 10.6M |
| Other income expense | — | — | — | — |
| Pretax income | 1.1B | 1.9B | 1.5B | 1.2B |
| Tax provision | 225.0M | 339.4M | 319.3M | 354.4M |
| Net income | 852.5M | 1.6B | 1.2B | 889.6M |
| Basic EPS | 3 | — | 4.3 | 2.8 |
| Diluted EPS | 3.0 | — | 4.3 | 2.8 |
| Basic average shares | 286.8M | — | 287.3M | 316.3M |
| Diluted average shares | 287.8M | — | 287.3M | 316.3M |
| EBITDA | 1.2B | 1.9B | 1.6B | 1.3B |
| Net income from continuing op. | 1.1B | 1.9B | 1.5B | 1.2B |
| Minority interests | 7.9M | 3.6M | 2.8M | 4.7M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |